SEARCH

SEARCH BY CITATION

References

  • Breckwoldt M. O., Chen J. W., Stangenberg L., Aikawa E., Rodriguez E., Qiu S., Moskowitz M. A. and Weissleder R. (2008) Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc. Natl Acad. Sci. USA 105, 1858418589.
  • Brown R. C. and Davis T. P. (2005) Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem. Biophys. Res. Commun. 327, 11141123.
  • Burggraf D., Martens H. K., Jager G. and Hamann G. F. (2003) Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia. Thromb. Haemost. 89, 10721080.
  • Candelario-Jalil E., Gonzalez-Falcon A., Garcia-Cabrera M., Leon O. S. and Fiebich B. L. (2007) Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J. Neurochem. 100, 11081120.
  • Candelario-Jalil E., Yang Y. and Rosenberg G. A. (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158, 983994.
  • Candelario-Jalil E., Thompson J., Taheri S., Grossetete M., Adair J. C., Edmonds E., Prestopnik J., Wills J. and Rosenberg G. A. (2011) Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke 42, 13451350.
  • Chiang N., Fierro I. M., Gronert K. and Serhan C. N. (2000) Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191, 11971208.
  • Conte F. P., Menezes-de-Lima O., Jr, Verri W. A., Jr, Cunha F. Q., Penido C. and Henriques M. G. (2010) Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects. Br. J. Pharmacol. 161, 911924.
  • Culman J., Nguyen-Ngoc M., Glatz T., Gohlke P., Herdegen T. and Zhao Y. (2012) Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial. Exp. Neurol. 238, 243253.
  • Desilles J. P., Rouchaud A., Labreuche J. et al. (2013) Blood-brain barrier disruption is associated with increased mortality after endovascular therapy. Neurology 80, 844851.
  • Fanning A. S., Jameson B. J., Jesaitis L. A. and Anderson J. M. (1998) The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 273, 2974529753.
  • Fischer S., Wobben M., Marti H. H., Renz D. and Schaper W. (2002) Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc. Res. 63, 7080.
  • Gidday J. M., Gasche Y. G., Copin J. C., Shah A. R., Perez R. S., Shapiro S. D., Chan P. H. and Park T. S. (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood–brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 289, H558H568.
  • Godson C., Mitchell S., Harvey K., Petasis N. A., Hogg N. and Brady H. R. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 16631667.
  • Gong J., Guo S., Li H. B., Yuan S. Y., Shang Y. and Yao S. L. (2012) BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation 83, 907912.
  • Gurney K. J., Estrada E. Y. and Rosenberg G. A. (2006) Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 23, 8796.
  • Hamann G. F., Liebetrau M., Martens H., Burggraf D., Kloss C. U., Bultemeier G., Wunderlich N., Jager G. and Pfefferkorn T. (2002) Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 22, 526533.
  • Hawkins B. T. and Davis T. P. (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173185.
  • Hawkins K. E., DeMars K. M., Yang C., Rosenberg G. A. and Candelario-Jalil E. (2013) Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke. Mol. Brain 6, 14.
  • Iadecola C. and Anrather J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796808.
  • Ishikawa M., Cooper D., Arumugam T. V., Zhang J. H., Nanda A. and Granger D. N. (2004) Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J. Cereb. Blood Flow Metab. 24, 907915.
  • Ji K. and Tsirka S. E. (2012) Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J. Neuroinflammation 9, 159.
  • Joo S. P., Xie W., Xiong X., Xu B. and Zhao H. (2013) Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice. Neuroscience 243, 149157.
  • Jucker M., Bialobok P., Kleinman H. K., Walker L. C., Hagg T. and Ingram D. K. (1993) Laminin-like and laminin-binding protein-like immunoreactive astrocytes in rat hippocampus after transient ischemia. Antibody to laminin-binding protein is a sensitive marker of neural injury and degeneration. Ann. N. Y. Acad. Sci. 679, 245252.
  • Kubota K., Furuse M., Sasaki H., Sonoda N., Fujita K., Nagafuchi A. and Tsukita S. (1999) Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr. Biol. 9, 10351038.
  • Latour L. L., Kang D. W., Ezzeddine M. A., Chalela J. A. and Warach S. (2004) Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56, 468477.
  • Lee T. H., Lympany P., Crea A. E. and Spur B. W. (1991) Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. Biochem. Biophys. Res. Commun. 180, 14161421.
  • Levy B. D., Zhang Q. Y., Bonnans C. et al. (2011) The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukot. Essent. Fatty Acids 84, 4350.
  • Li Y. S., Wu P., Zhou X. Y. et al. (2008) Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC. Arch. Biochem. Biophys. 478, 110118.
  • Maddox J. F., Hachicha M., Takano T., Petasis N. A., Fokin V. V. and Serhan C. N. (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 69726978.
  • Ogata Y., Enghild J. J. and Nagase H. (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267, 35813584.
  • Perretti M., Chiang N., La M., Fierro I. M., Marullo S., Getting S. J., Solito E. and Serhan C. N. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8, 12961302.
  • Rosell A., Cuadrado E., Ortega-Aznar A., Hernandez-Guillamon M., Lo E. H. and Montaner J. (2008) MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39, 11211126.
  • Rosenberg G. A., Estrada E. Y. and Dencoff J. E. (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29, 21892195.
  • Sobrado M., Pereira M. P., Ballesteros I. et al. (2009) Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 29, 38753884.
  • Sodin-Semrl S., Spagnolo A., Mikus R., Barbaro B., Varga J. and Fiore S. (2004) Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int. J. Immunopathol. Pharmacol. 17, 145156.
  • Strbian D., Karjalainen-Lindsberg M. L., Tatlisumak T. and Lindsberg P. J. (2006) Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J. Cereb. Blood Flow Metab. 26, 605612.
  • Suzuki Y., Nagai N., Umemura K., Collen D. and Lijnen H. R. (2007) Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J. Thromb. Haemost. 5, 17321739.
  • Svensson C. I., Zattoni M. and Serhan C. N. (2007) Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J. Exp. Med. 204, 245252.
  • Swanson R. A., Morton M. T., Tsao-Wu G., Savalos R. A., Davidson C. and Sharp F. R. (1990) A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290293.
  • Wada K., Arita M., Nakajima A., Katayama K., Kudo C., Kamisaki Y. and Serhan C. N. (2006) Leukotriene B4 and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation. FASEB J. 20, 17851792.
  • Warach S. and Latour L. L. (2004) Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35, 26592661.
  • Wu Y., Ye X. H., Guo P. P., Xu S. P., Wang J., Yuan S. Y., Yao S. L. and Shang Y. (2010) Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia. J. Mol. Neurosci. 42, 226234.
  • Wu Y., Wang Y. P., Guo P., Ye X. H., Wang J., Yuan S. Y., Yao S. L. and Shang Y. (2012) A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury. J. Mol. Neurosci. 46, 483491.
  • Yang Y., Estrada E. Y., Thompson J. F., Liu W. and Rosenberg G. A. (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697709.
  • Ye X. H., Wu Y., Guo P. P., Wang J., Yuan S. Y., Shang Y. and Yao S. L. (2010) Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res. 1323, 174183.
  • Yoon J. S., Lee J. H., Tweedie D., Mughal M. R., Chigurupati S., Greig N. H. and Mattson M. P. (2013) 3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. J. Neurosci. Res. 91, 671680.
  • Zhang J. W. and Gottschall P. E. (1997) Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J. Neurosci. Methods 76, 1520.
  • Zhang L., Wan J., Li H. et al. (2007) Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatol. Res. 37, 948956.
  • Zhang L., Zhang X., Wu P. et al. (2008) BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflamm. Res. 57, 157162.
  • Zlokovic B. V. (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178201.